BB Biotech

BB Biotech invests in firms in the rapidly increasing biotechnology market and has 30 years of expertise as one of the world's leading investors in this field. It focuses its investments on publicly traded firms that are developing and commercializing innovative pharmaceuticals that provide excellent value to the healthcare system.

BB Biotech strives to offer an average annual double-digit return over the long term, surpassing the general market indexes by a wide margin. BB Biotech invests globally in fast-growing firms that develop and sell novel biotech pharmaceuticals.

BB Biotech has a method of carefully evaluating and selecting biotechnology enterprises with a long-term time horizon and having established products in the marketplace. When making investment decisions, BB Biotech relies on the long-standing experience of its distinguished Board of Directors as well as the investment research skills of Bellevue Asset Management AG's experienced investment management team.

Founded: 1993
Headquarters: Schaffhausen, Switzerland
Website: https://www.bbbiotech.ch/